Corneal absorption of a new riboflavin-nanostructured system for transepithelial collagen cross-linking.

Corneal collagen cross-linking (CXL) has been described as a promising therapy for keratoconus. According to standard CXL protocol, epithelium should be debrided before treatment to allow penetration of riboflavin into the corneal stroma. However, removal of the epithelium can increase procedure ris...

Full description

Bibliographic Details
Main Authors: Katia M Bottos, Anselmo G Oliveira, Patrícia A Bersanetti, Regina F Nogueira, Acácio A S Lima-Filho, José A Cardillo, Paulo Schor, Wallace Chamon
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3681906?pdf=render

Similar Items